These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11704779)

  • 1. Initial experience with octreotide in the pediatric population.
    Lam JC; Aters S; Tobias JD
    Am J Ther; 2001; 8(6):409-15. PubMed ID: 11704779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide or vasopressin for bleeding esophageal varices.
    Law AW; Gales MA
    Ann Pharmacother; 1997 Feb; 31(2):237-8. PubMed ID: 9034426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide therapy for control of acute gastrointestinal bleeding in children.
    Eroglu Y; Emerick KM; Whitingon PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):41-7. PubMed ID: 14676593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of octreotide in pediatric patients.
    Al-Hussaini A; Butzner D
    Saudi J Gastroenterol; 2012; 18(2):87-94. PubMed ID: 22421712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.
    Huang Y; Zhuang S; Li Y; Liu M; Chen H; Du M
    Indian J Pediatr; 2011 Mar; 78(3):345-7. PubMed ID: 20953848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms.
    Di Lorenzo C; Lucanto C; Flores AF; Idries S; Hyman PE
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):508-12. PubMed ID: 9822313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of octreotide in children with chronic gastrointestinal bleeding.
    Zellos A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):442-6. PubMed ID: 10776959
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential indications for octreotide in gastroenterology: summary of workshop.
    Burroughs AK; Malagelada R
    Digestion; 1993; 54 Suppl 1():59-67. PubMed ID: 8359570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
    O'Meara M; Cicalese MP; Bordugo A; Ambrosi A; Hadzic N; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):48-53. PubMed ID: 25162361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders.
    Mas E; Borrelli O; Broekaert I; de-Carpi JM; Dolinsek J; Miele E; Pienar C; Koninckx CR; Thomassen RA; Thomson M; Tzivinikos C; Benninga MA
    J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):1-6. PubMed ID: 34508049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study.
    Rengasamy S; Ali SM; Sistla SC; Lakshmi CP; Harichandra Kumar KT
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):386-92. PubMed ID: 25874510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 15. Octreotide.
    Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
    N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
    [No Abstract]   [Full Text] [Related]  

  • 16. Octreotide for arrest of peptic ulcer hemorrhage--a prospective, randomized controlled trial.
    Lin HJ; Perng CL; Wang K; Lee CH; Lee SD
    Hepatogastroenterology; 1995; 42(6):856-60. PubMed ID: 8847035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy.
    Blich M; Fruchter O; Edelstein S; Edoute Y
    Scand J Gastroenterol; 2003 Jul; 38(7):801-3. PubMed ID: 12889571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin for acute severe bleeding from portal hypertensive gastropathy.
    Kouroumalis EA; Koutroubakis IE; Manousos ON
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):509-12. PubMed ID: 9855068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of octreotide for asparaginase-induced acute pancreatitis.
    Sakaguchi S; Higa T; Suzuki M; Fujimura J; Shimizu T
    Int J Hematol; 2017 Aug; 106(2):266-268. PubMed ID: 28349445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.